|
LOBBYING REPORT |
Lobbying Disclosure Act of 1995 (Section 5) - All Filers Are Required to Complete This Page
2. Address
Address1 | MEDICAL CENTER BLVD. |
Address2 |
|
City | WINSTON-SALEM |
State | NC |
Zip Code | 27157 |
Country | USA |
3. Principal place of business (if different than line 2)
City |
|
State |
|
Zip Code |
|
Country |
|
|
5. Senate ID# 6781-12
|
||||||||
|
6. House ID# 325100000
|
TYPE OF REPORT | 8. Year | 2016 |
Q1 (1/1 - 3/31) | Q2 (4/1 - 6/30) | Q3 (7/1 - 9/30) | Q4 (10/1 - 12/31) |
9. Check if this filing amends a previously filed version of this report
10. Check if this is a Termination Report | Termination Date |
|
11. No Lobbying Issue Activity |
INCOME OR EXPENSES - YOU MUST complete either Line 12 or Line 13 | |||||||||
---|---|---|---|---|---|---|---|---|---|
12. Lobbying | 13. Organizations | ||||||||
INCOME relating to lobbying activities for this reporting period was: | EXPENSE relating to lobbying activities for this reporting period were: | ||||||||
|
|
||||||||
|
|
||||||||
Provide a good faith estimate, rounded to the nearest $10,000, of all lobbying related income for the client (including all payments to the registrant by any other entity for lobbying activities on behalf of the client). | 14. REPORTING Check box to indicate expense accounting method. See instructions for description of options. | ||||||||
Method A.
Reporting amounts using LDA definitions only
Method B. Reporting amounts under section 6033(b)(8) of the Internal Revenue Code Method C. Reporting amounts under section 162(e) of the Internal Revenue Code |
Signature | Digitally Signed By: JOANNE C. RUHLAND |
Date | 4/12/2016 2:13:11 PM |
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code HCR
16. Specific lobbying issues
Preparation for Childress Institute for Pediatric Trauma Congressional Roundtable Discussion before Energy and Commerce Committee scheduled for May 24, 2016; Labor/HHS FY 2017 funding in the Presidents proposed FY 2017 Budget, including funding for the Agency for Healthcare Research and Quality (AHRQ) and Title VII programs; supplemental funding to respond to the Zika virus; VA-Academic affiliations work including Delivering Opportunities for Care and Services for Veterans Act, (S. 1676), Veterans Choice Improvement Act of 2016, Improving Veterans Access to Care in the Community Act, (S. 2633), Enhanced Veterans Health Care Act, (H.R. 3879); Centers for Disease Control and Preventions Guidelines for Prescribing Opioids in Chronic Pain
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, Health & Human Services - Dept of (HHS)
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Joanne C. |
Ruhland |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code MED
16. Specific lobbying issues
Improving Health Information Technology Act, (S. 2511); implementation of the Cybersecurity Information Security Act of 2015 regarding best practices for protecting health care information from cyberattack; The FDA Device Accountability Act of 2015, (S. 1622); The Advancing Targeted Therapies for Rare Diseases Act of 2015, (S. 2030); The Advancing Research for Neurological Diseases Act of 2015, (S. 849); The Enhancing the Stature and Visibility of Medical Rehabilitation Research at the NIH Act, (S. 800); NIH Letter to Senate and House Appropriators; Ad Hoc Group letter to House and Senate Appropriators.
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, Health & Human Services - Dept of (HHS)
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Joanne C. |
Ruhland |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code MMM
16. Specific lobbying issues
Graduate Medical Education payment reductions in the Presidents FY 2017 budget proposal; GAO Report on healthcare workforce programs and planning related to physician shortages; Resident Physician Shortage Reduction Act of 2015, (S. 1148, H.R. 2124); 340(B) Drug Pricing Program and Audit Results; Establishing Beneficiary Equity in the Hospital Readmission Program Act, (S. 688, H.R. 1343) regarding the need to appropriately adjust outcome measures for sociodemographic factors; House and Senate sign-on letters to the Center for Medicare and Medicaid Services (CMS) calling for a delay and modifications to the planned release of the Hospital Compare star ratings; Medicaid reform proposals and information regarding 1115 waivers; site-neutral payments language contained in the Bipartisan Budget Act.
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, Centers For Medicare and Medicaid Services (CMS), Health & Human Services - Dept of (HHS), Health Resources & Services Administration (HRSA)
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Joanne C. |
Ruhland |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code TAX
16. Specific lobbying issues
Tax Reform Discussions (Historic Tax Credit) and Tax Extenders; Tax-exempt status for non-profits
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Joanne C. |
Ruhland |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
Information Update Page - Complete ONLY where registration information has changed.
20. Client new address
Address |
|
||||||
City |
|
State |
|
Zip Code |
|
Country |
|
21. Client new principal place of business (if different than line 20)
City |
|
State |
|
Zip Code |
|
Country |
|
22. New General description of client’s business or activities
LOBBYIST UPDATE
23. Name of each previously reported individual who is no longer expected to act as a lobbyist for the client
|
|
||||||||
1 |
|
3 |
|
||||||
2 |
|
4 |
|
ISSUE UPDATE
24. General lobbying issue that no longer pertains
|
|
|
|
|
|
|
|
|
AFFILIATED ORGANIZATIONS
25. Add the following affiliated organization(s)
Internet Address:
Name | Address |
Principal Place of Business (city and state or country) |
||||||||||||
| ||||||||||||||
|
26. Name of each previously reported organization that is no longer affiliated with the registrant or client
1 | 2 | 3 |
FOREIGN ENTITIES
27. Add the following foreign entities:
Name | Address |
Principal place of business (city and state or country) |
Amount of contribution for lobbying activities | Ownership percentage in client | ||||||||||
| ||||||||||||||
|
% |
28. Name of each previously reported foreign entity that no longer owns, or controls, or is affiliated with the registrant, client or affiliated organization
1 | 3 | 5 |
2 | 4 | 6 |